The Newcastle MIC is funded by the National Institute for Health Research (NIHR) and is a partnership between Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University

There has typically been a perception that companies making In Vitro Diagnostics (IVDs) have been dissuaded from investing in the UK due to a fragmented and heavily regulated evaluation system that results in many new tests never reaching the NHS and benefiting patients.

The NIHR MICs will build expertise and capacity in the NHS to provide evidence on commercially supplied In Vitro Diagnostic (IVD) tests.

This will take diagnostic tests through rigorous clinical and economic evaluation.  With this objective, high-quality evidence can then be used by companies to demonstrate the value of their product to the NHS. 

At the core of the NIHR Newcastle MIC's service is medical research excellence, and the availability of large, well-characterised groups of patients, and tissue and blood samples held in our biobanks . Our aim is to provide a smooth, fast, responsive system that is attractive to IVD companies of all sizes, which leads to a far greater proportion of high quality, cost-effective diagnostic tests entering the NHS for patient benefit.

The NIHR Newcastle MIC will work with companies across three clinical themes
  • Stratified Medicine (led by Prof. Nick Reynolds, Director of Newcastle’s
  • MRC/EPSRC Molecular Pathology Node)
  • Ageing and Long-Term Conditions (led by Dr. James Frith, Senior Clinical Lecturer in Geriatric Medicine)
  • Infection (led by Dr. Ashley PriceConsultant in Infectious Diseases and Director of Infection Prevention and Control at NuTH)
The NIHR Newcastle MIC works closely with the NIHR Newcastle Biomedical Research Centre (BRC) by researching diagnostic tests for long-term conditions associated with ageing.